About Celltrix
Celltrix is a company based in Malma (Sweden) founded in 2004. It operates as a B2B. Celltrix has raised $3.81 million across 1 funding round from investors including SEED Capital and Novo Holdings. Celltrix operates in a competitive market with competitors including Avita Medical, RevBio, Dimension Inx, PolyNovo and LambdaVision, among others.
- Headquarter Malma, Sweden
- SectorsHealthcare
- Website celltrix.se
- Total Equity Funding$3.81M (USD)
in 1 rounds
- Latest Funding Round$3.81M (USD), Series A
May 2006
- InvestorsSEED Capital
& 1 more
Funding Insights of Celltrix
Celltrix has successfully raised a total of $3.81M through 1 strategic funding round. The most recent funding activity was a Series A round of $3.81 million completed in May 2006. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $3.81M
- Total Rounds 1
- Last Round Series A — $3.81M
- First Round $3.81M
(May 2006)
- Investors Count 2
All 1 funding rounds of Celltrix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2006 | $3.81M | Series A | – | Seed Capital, Novo Holdings | – |
2 investors in total: 2 institutional.
Investors in Celltrix
Celltrix has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include SEED Capital and Novo Holdings.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backing Nordic tech startups from seed to Series A with investments in Consumer, Deep Tech, and related sectors. | – | seedcapital.dk | - | |
Private equity and venture capital fund focused on the healthcare sector | – | novoholdings.dk | Hellerup, Denmark |
Investor details for Celltrix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Celltrix
2 dated milestones of Celltrix across 2 years, from founding to its latest funding, stage changes and deals.
- Founded Celltrix is founded.
- Funding First funding round of $3.8M.
Competitors of Celltrix
Celltrix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avita Medical, RevBio, Dimension Inx, PolyNovo and LambdaVision, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| avitamedical.com | 1992 | Cambridge, United Kingdom | – | 108 | Products for regenerative and respiratory medicine are developed and distributed. | |
| revbio.com | 2014 | Lowell, United States | $24.42M | – | Synthetic adhesives for bone and dental repair are developed. | |
| dimensioninx.com | 2017 | Chicago, United States | $15.42M | – | 3D biomaterials are provided for regenerative medicine applications. | |
| polynovo.com | 2004 | Port Melbourne, Australia | – | – | Developer of biodegradable temporising matrix for treating traumatic wounds | |
| lambdavision.com | 2009 | Farmington, United States | $650,000 | 7 | Protein-based retinal prosthesis for degenerative eye diseases is provided. | |
| gelformed.com | 2015 | Boston, United States | – | 9 | Gel4Med is focused on developing bioinspired medical solutions. | |
| profibrix.com | 2004 | Leiden, Netherlands | $33M | – | Powdered fibrin sealant for surgical bleeding | |
| walkingfishtx.com | 2019 | San Francisco, United States | $123M | – | Cell-based therapeutics for cancer and immunological disorders are developed. |
Detailed competitors of Celltrix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Celltrix
10 companies that operate in the same segment as Celltrix (Dermatology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Developer of drugs for treating dermatology diseases | 1908 | Copenhagen, Denmark | USD 560.38 M | – | – | |
Skincare, beauty, and wellness services provided by VLCC across multiple countries. | 1989 | Delhi, Delhi, India | – | – | – | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 | |
AI-powered drug discovery platform for various diseases | 2016 | New York, New York, United States | USD 608 M | – | – | |
Immunotherapeutic solutions for dermatological conditions are developed. | 2016 | Westlake Village, California, United States | USD 94.5 M | USD 376.07 M | 342 | |
Targeted small molecules are developed for oncology treatments. | 2010 | Singapore, Singapore | USD 100 M | – | – | |
Pharmaceutical formulations for dermatology, gastroenterology, and wellness are manufactured. | 2014 | Pune, Maharashtra, India | USD 25.97 M | USD 18.15 M | 508 | |
Novel dermatologic therapies are developed for skin conditions. | 2012 | Malvern, Pennsylvania, United States | USD 82 M | USD 7.83 M | 64 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celltrix
Celltrix was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Celltrix is headquartered in Malma, Sweden. It is registered at Malma, Stockholm County, Sweden.
Celltrix is a funded company, having raised a total of $3.81M across 1 funding round to date. The company's 1st funding round was a Series A of $3.81M, raised on May 2006.
Celltrix specializes in reconstructive cosmetic surgery products for medical professionals, focusing on providing healthcare solutions, developing medical devices, producing cosmetics, and reconstructive surgery. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.
Celltrix's top competitors include Avita Medical, RevBio and PolyNovo.
Celltrix has 2 investors. Key investors include SEED Capital, and Novo Holdings.